Lataa...
Nanotechnology-Based Vaccines for Allergen-Specific Immunotherapy: Potentials and Challenges of Conventional and Novel Adjuvants under Research
The increasing prevalence of allergic diseases demands efficient therapeutic strategies for their mitigation. Allergen-specific immunotherapy (AIT) is the only causal rather than symptomatic treatment method available for allergy. Currently, AIT is being administered using immune response modifiers...
Tallennettuna:
| Julkaisussa: | Vaccines (Basel) |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
MDPI
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7349961/ https://ncbi.nlm.nih.gov/pubmed/32443671 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/vaccines8020237 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|